CBD Life Sciences Inc. (OTCMKTS:CBDL – Get Free Report) was the target of a significant drop in short interest in September. As of September 30th, there was short interest totaling 99,665 shares, a drop of 90.8% from the September 15th total of 1,085,000 shares. Based on an average daily volume of 7,245,919 shares, the short-interest ratio is presently 0.0 days.
CBD Life Sciences Price Performance
CBD Life Sciences stock remained flat at $0.00 during midday trading on Friday. 3,306,486 shares of the company’s stock were exchanged, compared to its average volume of 12,614,161. CBD Life Sciences has a 52-week low of $0.00 and a 52-week high of $0.00.
CBD Life Sciences Company Profile
CBD Life Sciences, Inc (OTCMKTS:CBDL) is a U.S.-based company associated with the development and marketing of cannabidiol (CBD) and other hemp-derived wellness products.
Its product activities have included CBD-focused consumer goods, such as dietary supplements and personal-care or topical products. The company has promoted these products for general wellness purposes and has operated primarily through online and direct-to-consumer sales channels.
Publicly available information about CBD Life Sciences’ current operations, geographic reach, product portfolio, and leadership is limited.
Recommended Stories
- Five stocks we like better than CBD Life Sciences
- Alphabet Introduces Gemini Agent—Can It Trigger a Breakout?
- Palantir’s Rally Puts Wall Street in Catch-Up Mode Ahead of November Earnings
- Tilray Finds a Path to Growth Without Waiting on U.S. Cannabis Reform
- Arista Networks Plugs Into All-Time Highs
Receive News & Ratings for CBD Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CBD Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
